A group of potassium-channel blockers-acetylcholine releasers: new potentials for Alzheimer disease? A review
- PMID: 1573033
A group of potassium-channel blockers-acetylcholine releasers: new potentials for Alzheimer disease? A review
Abstract
This review of the literature examines systematically the data currently available for potassium-channel blockers to reassess their clinical potential in Alzheimer disease. The conclusion is that potassium-channel blockers may have been dismissed prematurely for the treatment of Alzheimer disease, an impression supported by data indicating intimate relationships between potassium-channel blockade and cholinergic transmission.
Similar articles
-
Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release.J Psychiatry Neurosci. 1993 Nov;18(5):226-34. J Psychiatry Neurosci. 1993. PMID: 8297921 Free PMC article. Review.
-
Potassium channel blockers: could they work in Alzheimer disease?Alzheimer Dis Assoc Disord. 1991 Spring;5(1):25-30. doi: 10.1097/00002093-199100510-00003. Alzheimer Dis Assoc Disord. 1991. PMID: 2025421 Review.
-
[Cholinergic treatment strategies in Alzheimer's disease].Nervenarzt. 1986 Oct;57(10):558-69. Nervenarzt. 1986. PMID: 3785472 German. No abstract available.
-
Manipulation of the cholinergic system.Funct Neurol. 1997 May-Aug;12(3-4):187-91. Funct Neurol. 1997. PMID: 9218975 Review. No abstract available.
-
[Pharmacological treatment of primary degenerative dementia].Pol Tyg Lek. 1988 Feb 8;43(6):194-7. Pol Tyg Lek. 1988. PMID: 3043401 Review. Polish. No abstract available.
Cited by
-
Neuropathobiology of senile dementia and mechanism of action of nootropic drugs.Drugs Aging. 1994 Apr;4(4):285-303. doi: 10.2165/00002512-199404040-00002. Drugs Aging. 1994. PMID: 8019052 Review.
-
Butylidenephthalide blocks potassium channels and enhances basal tension in isolated guinea-pig trachea.Biomed Res Int. 2014;2014:875230. doi: 10.1155/2014/875230. Epub 2014 Jul 10. Biomed Res Int. 2014. PMID: 25114927 Free PMC article.
-
Lack of effect of Z-butylidenephthalide on presynaptic N-type Ca²⁺ channels in isolated guinea-pig ileum.Naunyn Schmiedebergs Arch Pharmacol. 2016 Feb;389(2):159-66. doi: 10.1007/s00210-015-1183-5. Naunyn Schmiedebergs Arch Pharmacol. 2016. PMID: 26497186
-
Butylidenephthalide antagonizes cromakalim-induced systolic pressure reduction in conscious normotensive rats.BMC Complement Altern Med. 2015 Oct 5;15:344. doi: 10.1186/s12906-015-0877-z. BMC Complement Altern Med. 2015. PMID: 26438097 Free PMC article.
-
Repositioning medication for cardiovascular and cerebrovascular disease to delay the onset and prevent progression of Alzheimer's disease.Arch Pharm Res. 2020 Sep;43(9):932-960. doi: 10.1007/s12272-020-01268-5. Epub 2020 Sep 9. Arch Pharm Res. 2020. PMID: 32909178 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical